Clinical study of duvelisib in combination with venetoclax in patients with cancer.
Phase of Trial: Phase I/II
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Duvelisib (Primary) ; Venetoclax (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2015 According to Infinity Pharmaceuticals media release, company is planning to initiate this trial by the end of 2015.
- 16 Jan 2015 New trial record